(E)-3-[4-(3-hydroxypropoxy)phenyl]prop-2-enoic acid | 191917-03-0

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 肉桂酸及其衍生物
• 英文名称: (E)-3-[4-(3-hydroxypropoxy)phenyl]prop-2-enoic acid
• CAS: 191917-03-0
• 化学式: C₁₂H₁₄O₄
• 分子量: 222.241
• InChiKey: FYOQLZFUIAQRHF-QPJJXVBHSA-N

物化性质

• 沸点：
  427.1±25.0 °C(Predicted)
• 密度：
  1.237±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  16
• 可旋转键数：
  6
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  66.8
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  [2-(2-甲基-1H-吲哚-1-基)乙基]胺 、 (E)-3-[4-(3-hydroxypropoxy)phenyl]prop-2-enoic acid 在 4-二甲氨基吡啶 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 作用下， 以 二氯甲烷 为溶剂， 反应 8.0h， 生成 (E)-3-(4-(3-hydroxypropoxy)phenyl)-N-(2-(2-methyl-1H-indol-1-yl)ethyl)acrylamide
  参考文献：
  名称：

  Lead Optimization Studies of Cinnamic Amide EP2 Antagonists

  摘要：

  Prostanoid receptor EP2 can play a proinflammatory role, exacerbating disease pathology in a variety of central nervous system and peripheral diseases. A highly selective EP2 antagonist could be useful as a drug to mitigate the inflammatory consequences of EP2 activation. We recently identified a cinnamic amide class of EP2 antagonists. The lead compound in this class (5d) displays anti-inflammatory and neuroprotective actions. However, this compound exhibited moderate selectivity to EP2 over the DP1 prostanoid receptor (similar to 10-fold) and low aqueous solubility. We now report compounds that display up to 180-fold selectivity against DP1 and up to 9-fold higher aqueous solubility than our previous lead. The newly developed compounds also display higher selectivity against EP4 and IP receptors and a comparable plasma pharmacokinetics. Thus, these compounds are useful for proof of concept studies in a variety of models where EP2 activation is playing a deleterious role.

  DOI：

  10.1021/jm5000672

文献信息

• COMPOSITION FORMING HEAT-CURED FILM HAVING PHOTO-ALIGNMENT PROPERTIES
  申请人：Nissan Chemical Industries, Ltd.

  公开号：EP2557102A1

  公开（公告）日：2013-02-13

  There is provided a material that exhibits high solvent resistance after the formation of a cured film, excellent photo-alignment capability relative to a polymerizable liquid crystal, satisfactory heat resistance, and high transparency and moreover, that can be dissolved in a glycol-based solvent, a ketone-based solvent, or a lactic acid ester-based solvent that is applicable to the production of an overcoating of a color filter, during the formation of the cured film. A composition for forming thermoset film having photo-alignment properties, comprising: a component (A) that is a compound having a photo-aligning group and a hydroxy group; and a component (B) that is a silicon isocyanate compound. A liquid crystal alignment layer formed from the thermoset film forming composition, and an optical device with a retardation layer obtained by use of the thermoset film forming composition.

  本发明提供了一种材料，该材料在形成固化膜后具有较高的耐溶剂性，与可聚合液晶相比具有优异的光对准能力，耐热性令人满意，透明度高，而且在形成固化膜期间可溶解在乙二醇基溶剂、酮基溶剂或乳酸酯基溶剂中，适用于生产彩色滤光片的外涂层。一种用于形成具有光对准特性的热固性薄膜的组合物，包括：组分（A），即具有光对准基团和羟基的化合物；以及组分（B），即硅异氰酸酯化合物。由该热固性成膜组合物形成的液晶配向层，以及通过使用该热固性成膜组合物而获得的具有延缓层的光学器件。
• US20140342086A1
  申请人：——

  公开号：US20140342086A1

  公开（公告）日：2014-11-20
• US9334366B2
  申请人：——

  公开号：US9334366B2

  公开（公告）日：2016-05-10